Accepting new patients

Dr. Sandra Hazra, MD

Hematology •  Female • Age 75

  11 Reviews
Dr. Hazra

Skylake Cancer Treatment Center

2610 Uhrmann Rd Klamath Falls, OR 97601
Accepting new patients

Make an Appointment

(541) 274-4171

Dr. Sandra Hazra, MD is a hematology specialist in Klamath Falls, OR and has been practicing for 43 years. She graduated from McGill U, Fac Med in 1969 and specializes in hematology.

At a Glance

  • Good patient care Patients said they had exceptional care at this hospital. See hospitals
  • Friendly staff Patients said the staff was friendly. See reviews

Insurance Check

Search for your insurance provider

Dr. Hazra accepts

Accepted insurance can change. Please double-check when making an appointment.

(541) 274-4171

Dr. Hazra accepts the following insurance:

Aetna
Aetna HMO
Choice Plus POS II
Anthem Blue Cross Blue Shield
Anthem Blue Cross Blue Shield HMO
Blue Cross Blue Shield
Blue Card PPO
Cigna
Cigna HMO
Cigna PPO
Open Access Plus
Coventry Health Care
Coventry Health America PPO
Humana
Choice Care PPO

Background Check

No malpractice claims found for Oregon
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Hazra's experience treating your condition or procedure

Dr. Hazra's Top Procedures and Conditions

Treatment Frequency
Cancer
high
high

Treatment Frequency

Dr. Hazra treats Cancer more than 82% of her peers

Dr. Hazra treats this condition more than 82% of her peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer
Blood Disorders
high
high

Treatment Frequency

Dr. Hazra treats Blood Disorders more than 80% of her peers

Dr. Hazra treats this condition more than 80% of her peers

Chronic Lymphocytic Leukemia
normal
normal

Treatment Frequency

Dr. Hazra treats Chronic Lymphocytic Leukemia more than 63% of her peers

Dr. Hazra treats this condition more than 63% of her peers

Dr. Hazra's conditions and procedures:

  • Acute Leukemia
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • All Lymphoma
  • Anemia
  • Antiphospholipid Syndrome (APS)
  • Autoimmune Diseases
  • Bleeding Disorders
  • Blood Disorders
  • Blood Disorders in Pregnancy
  • Bone Cancer
  • Bone Disorders
  • Bone Marrow Biopsy
  • Cancer
  • Central Nervous System Lymphoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Coagulation Defects in Pregnancy and Postpartum
  • Coagulation Disorders (incl. Hemophilia)
  • Cryoglobulinemia
  • Deep Vein Thrombosis (DVT)
  • Hemophilia
  • Hemophilia A
  • Hodgkin's Disease
  • Hypercoagulable State
  • Immune Thrombocytopenic Purpura (ITP)
  • Leukocytosis
  • Lymphocytosis
  • Lymphoma, Large Cell, Anaplastic
  • Lymphoma, Large-Cell
  • Lymphosarcoma
  • Macroglobulinemia (incl. Waldenstrom's )
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Multiple Myeloma
  • Mycosis Fungoides
  • Myelodysplastic Syndromes
  • Myeloproliferative Disorders
  • Neutropenia
  • Nodular Lymphoma
  • Non-Hodgkin's Lymphoma
  • Pancytopenia
  • Polycythemia Rubra Vera
  • Pregnancy-Related Disorders
  • Primary Central Nervous System Lymphoma
  • Primary Hypercoagulable State (incl. Factor V Leiden Disease)
  • Purpura
  • Qualitative Platelet Defects (incl. Glanzmann's Thrombasthenia)
  • Reticulosarcoma
  • Sickle Cell Disease
  • Thalassemia
  • Thrombocytosis
  • Thrombosis
  • Vascular Disease
  • Venous Embolism and Thrombosis
  • von Willebrand Disease

Dr. Hazra's Reviews

Likelihood to recommend Dr. Hazra

3.5

Based on 11 reviews

5 Stars
63.63636363636363%
(7)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
36.36363636363637%
(4)

Leave a review

How likely are you to recommend
Dr. Hazra?
(Select your rating)
Average Reported Wait Time
  • 16 – 30 minutes
Dr. Hazra's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Sandra Hazra, MD
Reply
She was completely and utterly rude. I was over 450 lb.'s and she told me that the weight made me look old and ugly. Maybe so, but that was unnecessary to say that. She told me that if I didn't get the gastric bypass, she wouldn't treat me anymore. I had Several health conditions that weren't diagnosed at the time. Some which may have attributed to some of the weight gain. I'm the past two and a half years, I have had a lot of them taken care of and went on my own diet. I have now lost over 180
Was this helpful?
thumbs up icon option
thumbs down icon option1
×Post a ResponseAre you Dr. Sandra Hazra, MD?

Leave a review

How was your experience with Dr. Hazra?

About Me

Biography

Dr. Sandra Hazra, MD is a hematology specialist in Klamath Falls, OR and has been practicing for 43 years. She graduated from McGill U, Fac Med in 1969 and specializes in hematology.

Specialties

  • Hematology

Board Certifications

  • Hematology
  • Internal Medicine

Education

1976
Albany Med Coll
Fellowship Hospital
1974
Albany Med Coll
Residency Hospital
1971
Montefiore Hosp Med Ctr
Residency Hospital
1970
Montefiore Hosp Med Ctr
Internship Hospital
1969
McGill U, Fac Med
Medical School

Awards

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Hazra treats patients.

Learn more

Sky Lakes Medical Center

Klamath Falls, OR

67% Patient experience rating, 2% lower than the national average